BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

GLOBAL HEALTH INVESTMENT CORPORATION — Receipts Report

LD-2 disclosure · 4th Quarter - Report

GLOBAL HEALTH INVESTMENT CORPORATION

via SL STRATEGIES, LLC

4th Quarter (Oct 1 - Dec 31) · 2025Posted Jan 23, 2026Filing document ↗LDA record ↗

Income$40Kfee reported

Client

Name: GLOBAL HEALTH INVESTMENT CORPORATION
Description: nonprofit supporting the development and financing of products and services for publicgood
Location: New York · United States of America

Registrant

Firm: SL STRATEGIES, LLC
Description: health care consulting firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Medical/Disease Research/Clinical Labs
Support for reauthorization of the Biomedical Advanced Research and Development Authority
LobbyistsSARA LOVE RAWLINGS · JORDAN TENENBAUM · MARY MOODY JOHNSON
Covered position (SARA LOVE RAWLINGS): U.S. Senate Committee on Appropriations
Covered position (MARY MOODY JOHNSON): U.S. Senate Committee on Health, Education, Labor and Pensions
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.